← FDA DRUG APPROVALS

FDA NDA · NDA215668

BENDAMUSTINE HYDROCHLORIDE

Sponsor: DR REDDYS LABS LTD

APPLICATION
NDA215668
TYPE
NDA
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
None (Tentative Approval)

Products

BENDAMUSTINE HYDROCHLORIDENone (Tentative Approval)
BENDAMUSTINE HYDROCHLORIDE 100MG/4ML (25MG/ML) · SOLUTION · INTRAVENOUS

Approval history

2021-11-12Type 5 - New Formulation or New Manufacturer · Original · standardLetterTA
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →